ANCHYRA Partners 13F Filing Shows Key Stake Shifts

ANCHYRA Partners LLC filed a Form 13F on April 17, 2026 disclosing its long equity holdings for the quarter ended March 31, 2026, according to the SEC filing posted via Investing.com. The filing reports total long positions valued at $124.3 million and shows concentration in a small number of large-cap technology names; the three largest holdings account for 52% of the portfolio by market value (SEC Form 13F, Apr 17, 2026). Quarter-over-quarter movements include a reported 28% increase in the firm's stake in NVDA and a 12% reduction in one legacy industrial holding (SEC filing). For institutional investors monitoring manager behavior, the filing provides a timely snapshot of positioning ahead of Q2 earnings and macro data releases.

Context

The April 17, 2026 Form 13F from ANCHYRA Partners covers the reporting period ending March 31, 2026 and was logged on EDGAR and syndicated by Investing.com on the filing date. Form 13F filings are mandatory for institutional investment managers with $100 million or more in qualifying assets; they disclose long positions in U.S.-listed securities and are not real-time indicators but provide a definitive record of holdings as of quarter end. ANCHYRA's reported $124.3 million in total long market value places it in the small-to-mid sized manager cohort but its concentration metrics are notable: a 52% allocation to three names is materially higher than the median 35% concentration seen among comparable managers in 2025 (Bloomberg manager universe, 2025 data).

The timeline is important: the positions disclosed reflect trades and allocations through March 31, 2026, before the uptick in macro data and the Federal Reserve’s policy remarks in early April that shifted volatility across equity markets. That timing means the 13F shows positioning prior to several market-moving events, including the April 7 CPI release and April 14 minutes from the FOMC — both of which affected growth-sensitive sectors such as semiconductors and software. Investors should treat the filing as a backward-looking but legally binding disclosure that helps triangulate manager intent and risk appetite.

Finally, comparison versus peers shows ANCHYRA’s tilt toward technology is more pronounced than two peer sets: hedge funds filing 13Fs with $100m–$500m in assets reported a median technology allocation of 38% at quarter end, versus ANCHYRA’s approximately 46% allocation (SEC Form 13F; Bloomberg peer dataset, Q1 2026). The firm’s weighting implies higher sector-specific beta and potential sensitivity to sector-level shocks, such as semiconductor supply news or large-cap tech earnings surprises.

Data Deep Dive

The filing lists specific line items with share counts and fair market values; the headline figure is $124.3 million in aggregate long positions as of March 31, 2026 (SEC filing, Apr 17, 2026). The top holding, represented by NVDA (NVIDIA Corporation), was disclosed at a market value of $32.9 million — roughly 26.4% of reported longs — marking a 28% QoQ increase in reported value from the prior 13F (SEC filings Q4 2025 vs Q1 2026). The second and third largest positions were reported in AAPL (Apple Inc.) at $18.6 million and MSFT (Microsoft Corp.) at $12.3 million, together constituting another 25.6% of the portfolio.

The filing also documents rotational activity: ANCHYRA reduced a previously material industrial position by 12% quarter-over-quarter, taking that line from $9.5 million to $8.4 million, while adding exposure to a mid-cap software name that represented 4.1% of the portfolio at quarter end. These changes suggest a rebalancing from cyclical industrial exposure into secular growth names during Q1, a move consistent with the broader manager community’s response to earlier inflation prints and forward earnings revisions.

On liquidity and turnover, the portfolio shows moderate turnover: roughly 18% of the visible long-book value changed by more than 20% QoQ, indicating selective reweighting rather than wholesale reallocation. The filing contains no listed short positions (13Fs only report long U.S. equities) and therefore should be combined with other disclosures — for example, Form 13D, 13G or derivatives footprints reported elsewhere — to form a complete view of net exposure.

Sector Implications

A 46% allocation to technology and a 26% single-name weight to NVDA imply that ANCHYRA’s performance will be heavily correlated with semiconductor and large-cap tech performance. If NVDA moves by +/-10%, the direct impact on the reported portfolio value would be approximately +/-2.6 percentage points, before considering correlated moves across other holdings. This concentration elevates idiosyncratic risk: positive NVDA news (product cycle, AI demand) could outperform peers, while semiconductor-specific supply or demand shocks could depress relative returns.

Comparatively, ANCHYRA’s reduction in industrial exposure signals a tactical de-risking from cyclicals into secular growth during a period when growth re-rating and AI adoption narratives dominated market flows. For sector allocators and risk committees, this shift is informative: it aligns with a broader reallocation trend witnessed among active managers during Q1 2026, which saw net inflows to tech-focused ETFs and outflows from industrial and materials ETFs (ETF flow data, Q1 2026, Lipper).

For counterparties and index-tracking strategies, the filing is a reminder that some active managers now carry concentrated weights that can amplify stock-level liquidity needs at rebalancing windows. Large blocks in single names, if traded in concentrated windows, can interact with market depth and execution cost models, particularly for names with high implied volatility.

Risk Assessment

Concentration risk is the principal headline risk here. With 52% of long assets in the top three holdings, ANCHYRA’s downside in a targeted drawdown could exceed that of more diversified peers by several percentage points. Market risk is compounded by sector concentration: semiconductors and large-cap tech historically exhibit higher beta to liquidity shocks and macro surprises. Stress-testing hypothetical 15% drawdowns in each of the top three positions suggests a portfolio value decline of approximately 7.8% solely from those moves, before considering cross-asset contagion.

Liquidity risk is moderate but non-trivial. While the top holdings are large-cap names with deep markets, ANCHYRA’s mid-cap additions and a handful of smaller positions could face execution slippage if the manager sought to rebalance materially. Operational risk should also be considered: Form 13F reveals only long U.S. equity holdings, not derivatives or short positions; absent other disclosures (13D/G, 13H, or proprietary reports), external stakeholders cannot fully quantify net exposures or hedges.

Regulatory and disclosure risk is limited — the filing appears timely and in compliance with SEC deadlines — but the information asymmetry between what is reportable on 13F versus what may be held via swaps or offshore vehicles persists. Trustees, allocators, and counterparties will want to cross-check ancillary filings and Prime Broker statements for a fuller picture.

Fazen Markets Perspective

Fazen Markets views ANCHYRA’s filing as a deliberate, tactical tilt rather than a high-conviction concentrated gamble. The 28% increase in NVDA exposure appears to be a Q1 response to positive idiosyncratic catalysts (AI-related revenue revisions and order-book strength), while the modest reduction in industrials signals risk-off repositioning ahead of inflation and rate-forward guidance. Contrarian risk managers should note that high concentration can work for and against managers: while it increases volatility, it also means conviction is demonstrable and can outperform if the concentrated names continue to re-rate.

From a portfolio construction lens, the disclosure underscores the importance of stress-testing for single-name shocks and implementing liquidity buffers for periods when large-cap tech moves exceed historical volatility. Strategic allocators could interpret ANCHYRA’s moves as confirmation of a broader market shift toward AI incumbents — an argument supported by Q1 ETF flow data that show net inflows of $18bn into AI/semiconductor-linked ETFs (ETFDB, Q1 2026). However, Fazen Markets warns against extrapolating a single 13F into an enduring trend; filings are lagged snapshots and should be combined with active manager engagement and real-time market signals.

Outlook

Looking ahead, watch two inputs that will determine whether ANCHYRA’s Q1 tilts pay off: company-level earnings revisions for the top holdings over the next two quarters, and macro data that influence growth-versus-value rotations (notably CPI and PCE prints in May and June 2026). If NVDA and other top holdings sustain upgrades and end-market demand remains intact, concentrated strategies such as ANCHYRA’s will likely benefit; if macro surprises prompt a risk-off swing, the same concentration could amplify downside.

Investors and counterparties should also monitor subsequent disclosures — including any amendments, 13D/13G submissions if positions cross regulatory thresholds, and monthly fund reporting where available. For those tracking manager behavior, cross-referencing this 13F with subsequent ETF flows and options market positioning can help discern whether the market is mirroring ANCHYRA’s allocations or trading ahead of them (see our equities and market research pages at equities and market research).

Bottom Line

ANCHYRA’s Apr 17, 2026 Form 13F discloses $124.3m in long U.S. equities with a high concentration—52% in the top three names—highlighting a tactically tech-heavy stance that raises both upside potential and idiosyncratic risk. Investors should treat the filing as a clear, dated signal of positioning and combine it with forward-looking earnings and macro indicators before drawing conclusions.

Disclaimer: This article is for informational purposes only and does not constitute investment advice.

FAQ

Q: Does the 13F show ANCHYRA’s short positions or derivative exposure?

A: No. Form 13F only reports long positions in U.S.-listed equity securities. To assess short or derivative exposure you would need access to other filings (13D/G for activist stakes, 13H for large traders if applicable) and broker or internal disclosures.

Q: How should allocators interpret the 52% concentration in top three positions?

A: A concentration at this level is above the peer median and implies higher idiosyncratic risk. Allocators typically combine such disclosure with conversation on position sizing, liquidity management, and hedging to determine fit within a diversified mandate.

Q: Could ANCHYRA’s positions materially move the market?

A: Given the top holdings are large-cap names (e.g., NVDA, AAPL, MSFT) with deep liquidity, single manager trades are unlikely to move markets absent forced selling or concentrated execution in thin windows. However, if multiple managers with similar positioning trade simultaneously, market impact can be non-linear.